Varenicline Solution Nasal Spray 0.03 Mg for the Treatment of Dry Eye Disease Following Photorefractive Keratectomy
VNS is a favorable dry eye treatment option for patients following PRK, particularly in patients hoping to avoid additional topical medications or punctal occlusion. The higher percentage of eyes with UCDVA of 20/16 or better in the treatment group may suggest optimization of epithelial recovery after PRK.
Authors
- Tanner J. Ferguson (ORCID: https://orcid.org/0000-0002-7754-0465)
- John G. Goertz
- Brandon Baartman
- Kristen Walton
Institutions
- Vance Thompson Vision (US)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/opth.s474747
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00